Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Mycobacterium leprae | PROBABLE HYDROLASE | 0.0052 | 0 | 0.5 |
Onchocerca volvulus | Matrix metalloproteinase homolog | 0.0095 | 0.1485 | 1 |
Schistosoma mansoni | voltage-gated cation channel | 0.0076 | 0.0819 | 0.0538 |
Mycobacterium tuberculosis | Probable peptidoglycan hydrolase | 0.0052 | 0 | 0.5 |
Loa Loa (eye worm) | fructose-1,6-bisphosphatase | 0.0341 | 1 | 1 |
Echinococcus granulosus | matrix metallopeptidase 7 M10 family | 0.0156 | 0.3591 | 0.302 |
Loa Loa (eye worm) | hypothetical protein | 0.0076 | 0.0819 | 0.0819 |
Trypanosoma brucei | fructose-1,6-bisphosphatase | 0.0341 | 1 | 1 |
Loa Loa (eye worm) | matrixin family protein | 0.0104 | 0.1782 | 0.1782 |
Loa Loa (eye worm) | calcium channel | 0.0076 | 0.0819 | 0.0819 |
Schistosoma mansoni | fructose-16-bisphosphatase-related | 0.0341 | 1 | 1 |
Schistosoma mansoni | high voltage-activated calcium channel Cav2A | 0.0076 | 0.0819 | 0.0538 |
Mycobacterium ulcerans | hydrolase | 0.0052 | 0 | 0.5 |
Brugia malayi | Matrixin family protein | 0.0104 | 0.1782 | 0.1782 |
Leishmania major | 0.0341 | 1 | 0.5 | |
Brugia malayi | Hemopexin family protein | 0.0061 | 0.0297 | 0.0297 |
Echinococcus multilocularis | matrix metallopeptidase 7 (M10 family) | 0.0156 | 0.3591 | 0.302 |
Schistosoma mansoni | high voltage-activated calcium channel Cav1 | 0.0076 | 0.0819 | 0.0538 |
Toxoplasma gondii | fructose-bisphospatase II | 0.0341 | 1 | 1 |
Trypanosoma cruzi | fructose-1,6-bisphosphatase, cytosolic, putative | 0.0341 | 1 | 1 |
Trypanosoma cruzi | fructose-1,6-bisphosphatase, cytosolic, putative | 0.0341 | 1 | 1 |
Loa Loa (eye worm) | matrixin family protein | 0.0095 | 0.1485 | 0.1485 |
Brugia malayi | Voltage-gated calcium channel, L-type, alpha subunit. C. elegans egl-19 ortholog | 0.0076 | 0.0819 | 0.0819 |
Echinococcus granulosus | fructose 16 bisphosphatase 1 | 0.0341 | 1 | 1 |
Onchocerca volvulus | Matrilysin homolog | 0.0095 | 0.1485 | 1 |
Echinococcus multilocularis | fructose 1,6 bisphosphatase 1 | 0.0341 | 1 | 1 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.